Loramyc miconazole regulatory update

BioAlliance said FDA accepted an NDA for Loramyc to treat oropharyngeal candidiasis. BioAlliance expects a decision in 1Q10. Earlier this year, FDA refused to file an NDA for the mucoadhesive buccal t...